170 related articles for article (PubMed ID: 37684602)
41. Roles of H19/miR-29a-3p/COL1A1 axis in COE-induced lung cancer.
Zhang H; Li X; Jia M; Ji J; Wu Z; Chen X; Yu D; Zheng Y; Zhao Y
Environ Pollut; 2022 Nov; 313():120194. PubMed ID: 36150622
[TBL] [Abstract][Full Text] [Related]
42. Circular RNA (circ)_0129047 upregulates bone morphogenetic protein receptor type 2 expression to inhibit lung adenocarcinoma progression by sponging microRNA (miR)-1206.
Xue X; Chen Y
Bioengineered; 2022 May; 13(5):12067-12087. PubMed ID: 35570745
[TBL] [Abstract][Full Text] [Related]
43. In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor.
Hong H; Yao S; Zhang Y; Ye Y; Li C; Hu L; Sun Y; Huang HY; Ji H
PLoS Genet; 2020 Nov; 16(11):e1009168. PubMed ID: 33137086
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y
IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186
[TBL] [Abstract][Full Text] [Related]
45. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.
Shen H; Wang L; Ge X; Jiang CF; Shi ZM; Li DM; Liu WT; Yu X; Shu YQ
Oncotarget; 2016 Apr; 7(15):20728-42. PubMed ID: 26989074
[TBL] [Abstract][Full Text] [Related]
47. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
48. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.
Liang L; Xu WY; Shen A; Cen HY; Chen ZJ; Tan L; Zhang LM; Zhang Y; Fu JJ; Qin AP; Lei XP; Li SP; Qin YY; Huang JH; Yu XY
Acta Pharmacol Sin; 2022 Nov; 43(11):2946-2955. PubMed ID: 35388129
[TBL] [Abstract][Full Text] [Related]
49. The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer.
Iwabuchi E; Miki Y; Kanai A; Miyashita M; Kijima G; Hirakawa H; Suzuki T; Ishida T; Sasano H
J Pathol; 2018 Nov; 246(3):379-389. PubMed ID: 30058236
[TBL] [Abstract][Full Text] [Related]
50. miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells.
Li J; Wang Y; Song Y; Fu Z; Yu W
Mol Cancer; 2014 Aug; 13():193. PubMed ID: 25128483
[TBL] [Abstract][Full Text] [Related]
51. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
52. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
[TBL] [Abstract][Full Text] [Related]
53. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
Kaplan AR; Pham H; Liu Y; Oyaghire S; Bahal R; Engelman DM; Glazer PM
Mol Cancer Res; 2020 Jun; 18(6):873-882. PubMed ID: 32098827
[TBL] [Abstract][Full Text] [Related]
54.
Wang Z; Zhou L; Chen B; Li X; Zou Q; Xu W; Fang L; Wu A; Li Z; Chen Y
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107669
[TBL] [Abstract][Full Text] [Related]
55. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.
Zhao Z; Zhang L; Yao Q; Tao Z
Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211
[TBL] [Abstract][Full Text] [Related]
56. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
Li R; Liu J; Li Q; Chen G; Yu X
Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
Wu F; Chen Y; Li D; Wang Z; Yu M
Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
[TBL] [Abstract][Full Text] [Related]
58. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.
Watt K; Newsted D; Voorand E; Gooding RJ; Majewski A; Truesdell P; Yao B; Tuschl T; Renwick N; Craig AW
Cell Signal; 2018 Oct; 50():25-36. PubMed ID: 29935234
[TBL] [Abstract][Full Text] [Related]
60. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X
Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
